Avestar Capital, LLC Repligen Corp Transaction History

Avestar Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$161.19 - $257.96 $470,835 - $753,501	-2,921 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$247.59 - $304.47 $287,451 - $353,489	-1,161 Reduced 28.44%	2,921 $774,000
Q3 2021 Nov 09, 2021	BUY	$194.77 - $324.21 $795,051 - $1.32 Million	4,082 New	4,082 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $12,264 - $15,281	-160 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $5,204 - $6,227	160	160 $5,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.